Related Experiment Video
Updated: Jul 1, 2025

Author Spotlight: Uncovering the Role of Mitochondrial Calcium Phosphate in Heart Failure and Bioenergetics
Published on: August 23, 2024
Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function
Pankaj Patyal1, Xiaomin Zhang1, Ambika Verma1
1Donald W. Reynolds Department of Geriatrics and Institute on Aging, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract:
RhoA-regulated gene transcription by serum response factor (SRF) and its transcriptional cofactor myocardin-related transcription factors (MRTFs) signaling pathway has emerged as a promising therapeutic target for pharmacological intervention in multiple diseases. Altered mitochondrial metabolism is one of the major hallmarks of cancer, therefore, this upregulation is a vulnerability that can be targeted with Rho/MRTF/SRF inhibitors. Recent advances identified a novel series of oxadiazole-thioether compounds that disrupt the SRF transcription, however, the direct molecular target of these compounds is unclear. Herein, we demonstrate the Rho/MRTF/SRF inhibition mechanism of CCG-203971 and CCG-232601 in normal cell lines of human lung fibroblasts and mouse myoblasts. Further studies investigated the role of these molecules in targeting mitochondrial function. We have shown that these molecules hyperacetylate histone H4K12 and H4K16 and regulate the genes involved in mitochondrial function and dynamics. These small molecule inhibitors regulate mitochondrial function as a compensatory mechanism by repressing oxidative phosphorylation and increasing glycolysis. Our data suggest that these CCG molecules are effective in inhibiting all the complexes of mitochondrial electron transport chains and further inducing oxidative stress. Therefore, our present findings highlight the therapeutic potential of CCG-203971 and CCG-232601, which may prove to be a promising approach to target aberrant bioenergetics.
Insights
Novel oxadiazole-thioether compounds, CCG-203971 and CCG-232601, inhibit Rho/MRTF/SRF signaling. These compounds target mitochondrial function by altering gene expression, offering potential therapeutic strategies for diseases involving aberrant bioenergetics.
Area of Science:
- Molecular Biology
- Biochemistry
- Cancer Research
Background:
- The RhoA/SRF/MRTFs pathway is a key regulator of gene transcription and a therapeutic target for various diseases.
- Mitochondrial dysfunction and altered metabolism are hallmarks of cancer, presenting a vulnerability for targeted therapies.
- Novel oxadiazole-thioether compounds disrupt SRF transcription, but their precise molecular targets and mechanisms remain unclear.
Purpose of the Study:
- To elucidate the Rho/MRTF/SRF inhibition mechanism of CCG-203971 and CCG-232601.
- To investigate the role of these compounds in targeting mitochondrial function and bioenergetics.
- To explore the therapeutic potential of these molecules in diseases characterized by aberrant cellular metabolism.
Main Methods:
- Utilized normal human lung fibroblasts and mouse myoblasts to study Rho/MRTF/SRF inhibition.
- Investigated the effects of CCG-203971 and CCG-232601 on histone modifications, specifically H4K12 and H4K16 acetylation.
- Analyzed gene expression related to mitochondrial function and dynamics.
- Assessed the impact of the compounds on mitochondrial electron transport chain complexes and cellular respiration.
Main Results:
- CCG-203971 and CCG-232601 were demonstrated to inhibit the Rho/MRTF/SRF signaling pathway.
- These compounds induce hyperacetylation of histone H4K12 and H4K16, regulating genes involved in mitochondrial function and dynamics.
- The inhibitors repress oxidative phosphorylation, increase glycolysis, inhibit all mitochondrial electron transport chain complexes, and induce oxidative stress.
- These effects suggest a compensatory mechanism to regulate mitochondrial function.
Conclusions:
- CCG-203971 and CCG-232601 effectively inhibit Rho/MRTF/SRF signaling and target mitochondrial bioenergetics.
- The compounds' ability to induce oxidative stress and alter metabolic pathways highlights their therapeutic potential.
- These findings suggest a promising strategy for targeting aberrant bioenergetics in diseases like cancer.
Related Concept Videos
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

